A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (rg7713) in high-functioning adults with autism spectrum disorder

Daniel Umbricht, Marta Del Valle Rubido, Eric Hollander, James T. McCracken, Frederick Shic, Lawrence Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante, Christophe Grundschober, Heidemarie Kletzl, Paulo Fontoura

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (rg7713) in high-functioning adults with autism spectrum disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences